EasyCheck-Diabetes

Easycheck Diabetes: An Annual Blood Test to Detect Diabetes Associated Cancers

EasyCheck is an advanced non-invasive blood test that provides evidence of an underlying malignancy using a safe, simple, and quick blood draw.

EasyCheck Diabetes is a test to screen for the presence of cancer in individuals (above age 30 yrs) with existing or recently diagnosed type 2 diabetes.  Diabetic patients are more likely to be affected with diabetes-related cancers originating in the kidneys, colon, rectum, pancreas, liver, and bladder than healthy individuals. This test plays a vital role in screening diabetic patients for related cancers and mitigating their complications.

EasyCheck is designed to detect Circulating Tumor Cells (CTCs), which are cancer cells that escape from the tumor and enter the bloodstream. EasyCheck enriches these CTCs from the blood sample.

 Panels covered

This test is validated for the detection of the following types of malignancies only:

Liver (AD - HCC), Pancreaticobiliary (Pancreas (AD), Bile Duct (AD) Gallbladder (AD)), Colon (AD), Rectum (AD), Kidney (RCC), Bladder (UC) 

Who should get tested?

EasyCheck is intended to be performed annually as a screening test, in individuals aged 30 years and above, who have no past history of cancer and are without any symptoms suggestive of cancer.

What does the report tell me?

The report will tell you if CTCs were detected (indicating a higher risk of the presence of carcinoma) or CTCs were not detected (indicating a lower risk of the presence of carcinoma) in the submitted sample. When Circulating Tumor Cells are detected, the results can indicate the location of the tumor in the body, allowing your healthcare practitioner to advise your next steps.

How to read the report?

For Positive report: Individuals with these findings are advised to consult with their physician for appropriate guidance and additional standard of care workup as may be advised.

For Negative report: EasyCheck test may be repeated annually and the individual is advised to consult a physician if further guidance is required.

Please Note: If the sample indicates malignancy but is either negative or indeterminate with regard to its subtype, further investigation besides the EasyCheck-Diabetes test may be considered as advised by your physician. After this screening test, further decisions on patient care and treatment must be based on the independent medical judgment of the treating physicians taking into consideration all available and relevant information concerning the patient's condition, such as personal and family history, physician's examination as well as information from other pertinent diagnostic tests and medical imaging and histopathology.